mouse monoclonal IgG2a; VEGF-C Antibody (E-6) is an IgG2a κ mouse monoclonal VEGF-C antibody that detects the VEGF-C protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. VEGF-C Antibody (E-6) is available as both the non-conjugated anti-VEGF-C antibody form, as well as multiple conjugated forms of anti-VEGF-C antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). VEGF is a dimeric glycoprotein with structural homology to PDGF. Several variants of VEGF have been described that arise by alternative mRNA splicing. It has been speculated that VEGF may function as a tumor angiogenesis factor in vivo. Two additional proteins, designated VEGF-B and VEGF-C, share a significant degree of homology with VEGF. VEGF-B is abundantly expressed in heart and skeletal muscle and is frequently coexpressed with VEGF. VEGF-C binds to and specifically activates Flt-4 and Flk-1. The genes that encode VEGF-B and VEGF-C have been localized to chromosomes 11q13.1 and 4q34.3, respectively.

Free sample available. Limit 3 free samples for each full size Santa Cruz Biotechnology primary antibody ordered. All samples must be different. Customer responsible for shipping costs.